Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Graphic Truth: National Institutes for Health funding in peril
The Trump administration wants to slash the budget of the National Institutes of Health (NIH), the US’ main medical research institution, by 40% for the next fiscal year.
The move would bring funding levels back to those of the early 1990s, before a huge post-Cold War push to increase non-military R&D nearly doubled the NIH budget.
The current, Trump-appointed NIH Director Dr. Jay Bhattacharya reaffirmed his agency’s commitment to addressing “the health needs of all Americans” before the senate on Tuesday. At the same time, more than 300 current and recently terminated NIH employees have accused the director of suspending federal grant funding for ideological reasons.
Here’s a look at how Trump’s proposed cuts stack up against NIH funding over the past 30 years.
Coronavirus' effect on health may linger; expert warns of more patients with both flu and Covid-19
BEIJING (CHINA DAILY/ASIA NEWS NETWORK) - Covid-19 and related diseases may cause lasting health problems, with more than 70 per cent of patients who have recovered still showing at least one symptom after they are well, according to a study.
Indian scientists develop new paper-strip test for Covid 19
A fast and easy paper-strip test for Covid 19, much like a pregnancy test, is set to hit the market, and it could be a game changer for India as it seeks to curb the coronavirus pandemic.
Takeda-led Covid-19 plasma treatment enters clinical trial with first patient
TOKYO (REUTERS) - Japan's Takeda Pharmaceutical Co said on Friday (Oct 9) an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for Covid-19 after months of regulatory delays.
Coronavirus: One in three South Korean Covid-19 patients improve with remdesivir drug
SEOUL (REUTERS) - One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences's antiviral remdesivir, health authorities said.
Global trial of anti-malarial drug backed by Trump stalls
Recruitment of subjects for a major global trial to determine whether an anti-malarial drug can ward off the coronavirus has stalled, after the World Health Organisation (WHO) suspended its own clinical trials on treating Covid-19 patients.
Thailand cautiously reopens door to weed
NAKHON RATCHASIMA (Thailand)• • "Would you like to try it?" the young man says when he notices me peering at the cannabis joint held between his fingers. "It's good for your health." Behind him, a dark green banner declares: "Meet People with Experience in Kancha".